Physician profile
Julia Speciale
NPI 1740804509
$1,236.49
in general payments reported to CMS, 2019-2025
18 companies · $48.96 in 2025
The $48.96 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $579 · 2022: $581 · 2024: $27.08 · 2025: $48.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $366.05 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $171.01 | 2021-2022 | |
| Celgene Corporation | $120.77 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $109.74 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $102.80 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $92.12 | 2021-2022 | |
| Redhill Biopharma INC. | $56.26 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $32.98 | 2022 | |
| Qol Medical, LLC | $30.18 | 2021 | |
| Intercept Pharmaceuticals, INC. | $29.59 | 2021-2022 | |
| Avion Pharmaceuticals | $17.92 | 2021 | |
| Pfizer INC. | $17.20 | 2022 | |
| Supernus Pharmaceuticals, INC. | $17.16 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $17.16 | 2025 | Zurzuvae |
| Axonics, INC. | $15.80 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $14.64 | 2025 | Voquezna |
| Janssen Biotech, INC. | $12.94 | 2022 | |
| Coopersurgical, INC. | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Speciale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.